pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
iron · news · pharmadog
← back to iron
News mentioning iron
23
stories
14d
Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assets
fiercebiotech
20d
Kairon Health raises $5M to use data to make patients healthier
endpoints
25d
A booming business on Wall Street would love more biotechs to quietly die
biopharma dive
26d
Opinion: John Fetterman’s post-stroke, politically problematic behaviors offer lessons about brain health on Capitol Hill
stat
Sep 4, 26
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
biopharma dive
Aug 31, 26
FDA OKs Takeda, Protagonist drug for rare blood cancer
biopharma dive
Aug 31, 26
Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunity
biospace
Aug 28, 26
FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
fda press
Aug 25, 26
Amgen, academic centers weigh new FDA pilot to speed early drug trials
endpoints
Aug 13, 26
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
biospace
Aug 13, 26
Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision
fiercebiotech
Aug 11, 26
Vaderis fuels up with $152M series B to test rare vascular disease in Phase 3
biospace
Aug 11, 26
After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
fiercebiotech
Aug 10, 26
Silence brings the noise to Takeda with phase 2 blood cancer win
fiercebiotech
Jul 31, 26
Syphilis spreads while researchers contend with federal constraints and a drug shortage
stat
Jul 30, 26
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
biospace
Jul 29, 26
‘Reverse mergers are increasingly popular’: Caldera hops on Synlogic’s Nasdaq listing
fiercebiotech
Jul 28, 26
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
stat
Jul 27, 26
Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency
stat
Jul 13, 26
Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahoma
stat
Jul 8, 26
Bryan Johnson’s chronic disease is notoriously difficult to diagnose
stat
Apr 30, 26
STAT+: Democrats go hard on health care affordability
stat
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: TriGemX tacks on $94M; AnaCardio adds $71M
fiercebiotech
